Insights into the effective use of the Smart <scp>MDI</scp> system: Data from the first 1852 type 1 diabetes users
User engagement with the Smart MDI system is crucial for optimal glycaemic outcomes. The study underscores the need for structured education on system use and alert responses. While causality cannot be confirmed, the findings suggest that proactive user interactions contribute to meeting glycaemic targets. Further research is needed to explore these relationships and enhance educational strategies.
Authors
- Glen Im
- Ohad Cohen (ORCID: https://orcid.org/0000-0003-4337-1795)
- N. Shannon (ORCID: https://orcid.org/0000-0002-9361-6597)
- Tim R. A. van den Heuvel (ORCID: https://orcid.org/0000-0002-3907-6876)
- Peter Adolfsson (ORCID: https://orcid.org/0000-0001-7615-9737)
- Andrea Laurenzi (ORCID: https://orcid.org/0000-0002-6073-5098)
- Benedikt Voelker
- Fabio Di Piazza
Institutions
- Medtronic (Ireland) (IE)
- Medtronic (United States) (US)
- Södra Älvsborg Hospital (SE)
- IRCCS Ospedale San Raffaele (IT)
- University of Gothenburg (SE)
Publication Details
- Journal
- Diabetic Medicine
- Published
- 2025-10-13
- DOI
- https://doi.org/10.1111/dme.70161
- Primary Topic
- Diabetes Management and Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Eli Lilly and Company
- Sanofi
- Insulet Corporation
- Dexcom
- Novo Nordisk